Real-time enrollment status for this acute myeloid leukemia clinical trial
Current Status
Terminated
Checked: March 2, 2026 at 11:51 AM UTC
| NCT Number | NCT06563804 |
| Recruiting Status | Terminated |
| Condition | Acute Myeloid Leukemia |
| Phase | Clinical Trial |
| Target Enrollment | 132 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Servier Bio-Innovation LLC |
| Last Updated on CT.gov | October 14, 2025 (Oct 14, 2025) |
As of March 2, 2026: Clinical trial NCT06563804 is currently terminated participants. This clinical trial study for acute myeloid leukemia is not currently accepting new participants at 5 locations across the United States. The study is sponsored by Servier Bio-Innovation LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06563804 is currently terminated. The study may resume recruiting in the future.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06563804 was last updated Oct 14, 2025 (October 14, 2025). HelloStudys verifies this status automatically.